Background {#sec1}
==========

NSCL/P (Nonsyndromic cleft lip with or without cleft palate) is one of the most common birth defects, characterized by craniofacial abnormality due to incomplete separation between the nasal and oral cavities \[[@B1]\]. NSCL/P can influence the quality of life by affecting communication problems and contributing to dysphagia. Cleft lip and palate occur in approximately one in 500--700 live births worldwide. Cleft lip is a hereditary disease with polygenic inheritance, however, the underlying genetic cause and fundamental molecular mechanism of the disease remains still elusive. However, the incidence of cleft lip varies substantially across different ethnic groups and geographical areas (<http://www.who.int/oral_health/publications/factsheet/en/>).

Although folic acid and multivitamin supplementation in prescribed period of pregnancy has been indicated as an effective method to prevent the risk of oral facial cleft. The significance of genetic locus in folate pathway and folate metabolism involved in disease pathogenesis is not clear \[[@B2],[@B3]\]. Recently, many efforts have been made to find the genetic variants in folate pathway genes such as *MTHFR* (methylenetetrahydrofolate reductase), *MTRR* (Methionine synthase reductase), *TCN2* (transcobalamin 2), and *BHMT* (betaine-homocysteine methyltransferase) and their susceptibility to cleft lip \[[@B4]\]. MTHFR plays an important role in primary circulation of folate and catalyzing the reaction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. The substrate and metabolites are important for DNA biosynthesis, cell division and process during development. Currently, there is no targeted therapy for NSCL/P patients carried with *MTHFR* mutations, while there are some reports on other genetic diseases. In 2017, Martinez Saguer et al*.* reported successful management of hereditary angioedema during pregnancy in a patient carried with heterozygous *MTHFR* mutation \[[@B11]\]. Lahiri et al. reported successful conservative treatment of myocardial infarction in a teenager carried with *MTHFR* mutation \[[@B12]\]. Recently, Al-Eitan et al*.* also showed that *MTHFR* polymorphism was associated with treatment response in Jordanian population with epilepsy \[[@B13]\]. MTRR and TCN2 are essential in maintaining the levels of activated vitamin B12, and BHMT is vital for catalyzing betaine to dimethyl glycine (DMG), which are involved in remethylating Hcy (homocysteine) to Met (methionine) ([Figure 1](#F1){ref-type="fig"}). The four genetic missense variations 677C\>T in *MTHFR* (rs1801133), 66A\>G in *MTRR* (rs1801394), 776C\>G in *TCN2* (rs1801198), and 716 G\>A in *BHMT* (rs3733890) have influence on protein function ([Table 1](#T1){ref-type="table"}), and have been reported to be associated with cleft lip. However, there are different conclusions regarding the influence of these SNPs in different populations \[[@B4],[@B14]\].
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###### Information of four SNPs in the present study

  SNP         Gene      Codon           Polyphen2                      SIFT               CADD                PhyloP                 LRT
  ----------- --------- ------- ------- ---------------------- ------- ----------- ------ ----------- ------- -------------- ------- -------------
  rs1801133   *MTHFR*   C677T   0.998   probability damaging   0.027   damage      25.0   damaging    9.137   conserved      0       deleterious
  rs1801394   *MTRR*    A66G    1       probability damaging   0.064   tolerable   23.3   damaging    0.098   nonconserved   0       deleterious
  rs1801198   *TCN2*    C776G   0.315   benign                 0.09    tolerable   18.9   tolerable   0.081   nonconserved   0.027   neutral
  rs3733890   *BHMT*    G716A   0.064   benign                 0.218   tolerable   21.8   damaging    2.864   conserved      0.070   neutral

Here, a comprehensive bioinformatics analysis was used to predict the functional pathogenicity of genetic variation and a systematic review according to PRISMA2009 was performed to provide more precise statistical results. Our study could provide basic data for exploring effective therapeutic strategies for NSCL/P.

Methods {#sec2}
=======

Literature search {#sec2-1}
-----------------

All published studies before April 2019 were searched using the PubMed database, Embase database, and Google Scholar with the following terms: "NSCL/P", "cleft lip", "SNP", "polymorphism", "genetic", "variant", "MTHFR", "MTHFR C677T", "rs1801133", "MTRR", "MTRR A66G", "rs1801394", "TCN2", "TCN2 C776G", "rs1801198", "BHMT", "BHMT G716A", and "rs3733890". Relevant references of related articles were also included.

Inclusion criteria and exclusion criteria {#sec2-2}
-----------------------------------------

All studies were independently reviewed by two researchers. Studies were included in the meta-analysis if they met the following criteria: (1) original study of human participants; (2) an association study between rs1801133 and/or rs1801394 and/or rs1801198 and/or rs3733890 and NSCL/P; (3) case--control study or cohort study; (4) allele data were available; (5) the largest sample size or sufficient useful data were included in duplicate publications from the same population. Studies were excluded if they met the following criteria: (1) allele data were not available; (2) publications duplicate from the same population; and (3) review article and meta-analysis.

Quality score assessment {#sec2-3}
------------------------

The quality of research was evaluated to guarantee the strength of results and conclusions. The NOS (Newcastle--Ottawa scale) score was calculated to assess the quality of studies \[[@B42]\]. A maximum of nine scores, including selection, comparability and exposure items, could be awarded, \<4, 4--6, and \>6 indicate poor, moderate, and good quality, respectively. Any variances in comparison were decided by a third researcher.

Data extraction {#sec2-4}
---------------

The data were extracted independently by two researchers from all included studies using an integrated and standardized form. The following information was extracted: (1) first author name; (2) publication year; (3) population ethnicity; and (4) genotype distribution.

Computational and statistical analysis {#sec2-5}
--------------------------------------

Polyphen2, SIFT, CADD, phyloP, and LRT were used for bioinformatics prediction. The HWE (Hardy--Weinberg equilibrium) test was calculated by the chi-square test. The distribution of allelic frequencies in controls were considered to deviate from HWE when *P* \< 0.05. STATA (11.0; Stata Corporation, College Station, TX, U.S.A.) software was used to calculate the results of meta-analysis. Heterogeneity across individual studies was assessed by Cochran\'s *Q* test and *I^2^* statistic (*P* \< 0.10 and *I^2^* \> 50% indicated evidence of heterogeneity).The fixed-effects model (Mantel--Haenszel method) was used to estimate the pooled OR when there was no evidence of the heterogeneity; otherwise, the random-effects model analyzed by DerSimonian and Laird method was used. Using rs1801133 C\>T as an example: (1) allele model, T allele vs. C allele; (2) dominant model, (CT+TT vs. CC); (3) recessive model, (TT vs. CT+CC); and (4) genotype model, (CT vs. CC; TT vs. CC). The same genetic models were performed for "rs1801394", "rs1801198", and "rs3733890". A *P* value of *P* \< 0.05 was established as the significant difference. Two subgroups, including Caucasian and Asian, based on ethnicity were analyzed to reduce the heterogeneity and influences from the genetic background. Meta-regression, and one-way sensitivity analysis, and Egger's regression test were also performed \[[@B43]\]. The trim and fill method was used when publication bias exists.

Results {#sec3}
=======

Study characteristics {#sec3-1}
---------------------

According to the search strategy, 926 publications were identified in the initial search. After evaluating the titles and abstracts, 801 publications were excluded, and 125 full-text publications were further reviewed ([Figure 2](#F2){ref-type="fig"}). By applying the inclusion criteria, 34 publications were used for the final meta-analysis. Overall, 30 publications with 5517 cases and 7770 controls were included in the rs1801133 group; ten publications with 1767 cases and 2029 controls were included in the rs1801394 group; six publications with 1815 cases and 898 controls were included in the rs1801198 and five studies with 1253 cases and 1562 controls were included in the rs3733890 group. A total of seven studies in the control group (not excluded) were found to deviate from HWE. The main characteristics of the included publications are shown in [Table 2](#T2){ref-type="table"}.
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###### Characteristics of included studies about associations between four SNPs of folate pathway gene and NSCL/P

  Study                      Year   Ethnicity   Genotype in case   Genotype in control   *P* value of HWE test   NOS score   Source of control   Genotyping method                                                   
  -------------------------- ------ ----------- ------------------ --------------------- ----------------------- ----------- ------------------- ------------------- ----- ----- ----- ------- --------- --- ------- ---------------
  Shaw et al.                1998   Caucasian   310                143                   127                     40          0.334               383                 156   178   49    0.360   0.873     6   PB      PCR-
  Tolarova et al.            1998   Caucasian   111                43                    49                      19          0.392               106                 46    52    8     0.321   0.195     6   NA      NA
  Gaspar et al.              1999   Caucasian   77                 30                    39                      8           0.357               103                 49    49    5     0.286   0.096     6   HB      NA
  Wyszynski et al.           2000   Caucasian   259                114                   109                     36          0.349               327                 129   154   44    0.370   0.854     6   PB      Q-PCR, Taqman
  Martinelli et al.          2001   Caucasian   64                 22                    30                      12          0.422               106                 46    43    17    0.363   0.205     6   PB      PCR
  Grunert et al.             2002   Caucasian   66                 34                    26                      6           0.288               184                 90    69    25    0.323   0.052     6   PB      PCR
  Shotelersuk et al.         2003   Asian       109                84                    25                      0           0.115               202                 154   46    2     0.124   0.478     6   PB      PCR
  van Rooij et al.           2003   Caucasian   105                54                    45                      6           0.271               128                 70    54    4     0.242   0.091     6   PB      PCR
  Gaspar et al.              2004   Caucasian   644                327                   269                     48          0.283               424                 213   172   39    0.295   0.616     6   HB      PCR
  Pezzetti et al.            2004   Caucasian   110                28                    58                      24          0.482               289                 95    151   43    0.410   0.174     6   HB      PCR
  Brandalize et al.          2007   Caucasian   114                49                    46                      19          0.368               100                 45    41    14    0.345   0.353     6   HB      PCR
  Chevrier et al.            2007   Caucasian   148                66                    60                      22          0.351               165                 51    81    33    0.445   0.935     6   HB      PCR
  Little et al.              2008   Caucasian   96                 39                    47                      10          0.349               224                 94    101   29    0.355   0.819     6   PB      MS-PCR
  Mills et al.               2008   Caucasian   492                217                   221                     54          0.334               1599                715   721   163   0.327   0.341     7   HB      PCR
  Ali et al.                 2009   Asian       323                225                   87                      11          0.169               214                 176   36    2     0.093   0.916     6   PB      PCR
  Sozen et al.               2009   Caucasian   179                81                    80                      18          0.324               138                 66    65    7     0.286   0.073     6   PB      PCR
  Mostowska et al.           2010   Caucasian   163                81                    65                      17          0.304               171                 78    77    16    0.319   0.629     6   PB      PCR
  Ebadifar et al.            2010   Asian       61                 21                    18                      22          0.508               215                 114   72    29    0.302   0.003     6   PB      PCR
  Han et al.                 2011   Asian       187                46                    106                     35          0.471               213                 74    110   29    0.394   0.236     6   HB      PCR
  Aslar et al.               2013   Caucasian   80                 13                    57                      10          0.481               125                 59    62    4     0.280   0.010     6   PB      PCR
  Kumari et al.              2013   Asian       467                327                   125                     15          0.166               469                 364   100   5     0.117   0.518     6   Mixed   PCR
  Murthy et al.              2014   Asian       123                104                   19                      0           0.077               141                 107   31    3     0.131   0.672     6   HB      PCR
  Estandia-Ortega et al.     2014   Caucasian   132                39                    55                      38          0.496               370                 143   172   55    0.381   0.780     7   PB      PCR
  Jiang et al.               2015   Asian       204                59                    107                     38          0.449               226                 62    108   56    0.487   0.512     6   PB      Sequenom
  Bezerra et al.             2015   Caucasian   140                74                    54                      12          0.279               175                 85    70    20    0.314   0.341     6   PB      PCR
  Abdollahi-Fakhim et al.    2015   Asian       121                38                    58                      25          0.446               103                 27    54    22    0.476   0.605     6   PB      PCR
  Wang et al.                2016   Asian       147                28                    66                      53          0.585               129                 19    97    13    0.477   \<0.001   5   PB      PCR
  Marini et al.              2016   Caucasian   330                119                   159                     52          0.398               360                 148   154   58    0.375   0.097     7   HB      Taqman
  Karas Kuzelicki et al.     2018   Caucasian   103                45                    45                      13          0.345               199                 85    96    18    0.332   0.214     7   Mixed   Taqman
  Rafik et al.               2019   Africa      52                 44                    8                       0           0.077               182                 97    74    11    0.264   0.526     6   PB      PCR
  *MTRR* rs1801394                  Total       AA                 AG                    GG                      AF          Total               AA                  AG    GG    AF                                  
  Brandalize et al.          2007   Caucasian   114                36                    69                      9           0.382               100                 33    61    6     0.365   0.002     6   HB      PCR
  Mostowska et al.           2010   Caucasian   164                31                    81                      52          0.564               166                 34    70    62    0.584   0.089     6   PB      PCR
  Aslar et al.               2014   Caucasian   100                14                    72                      14          0.500               125                 13    107   5     0.468   \<0.001   6   PB      PCR
  Waltrick-Zambuzzi et al.   2015   Caucasian   342                95                    194                     53          0.439               401                 136   193   72    0.420   0.806     7   HB      Q-PCR
  Jiang et al.               2015   Asian       204                123                   71                      10          0.223               226                 124   84    18    0.265   0.480     6   PB      Sequenom
  Bezerra et al.             2015   Caucasian   140                98                    37                      5           0.168               175                 112   60    3     0.189   0.111     6   PB      PCR
  Murthy et al.              2015   Asian       123                42                    81                      0           0.329               141                 65    76    0     0.270   \<0.001   5   HB      PCR
  Wang et al.                2016   Asian       147                71                    26                      50          0.429               129                 29    59    41    0.547   0.380     5   PB      PCR
  Marini et al.              2016   Caucasian   330                160                   134                     36          0.312               367                 175   161   31    0.304   0.478     7   HB      Sequenom
  Karas Kuzelicki et al.     2018   Caucasian   103                14                    56                      33          0.592               199                 30    111   58    0.570   0.051     7   Mixed   PCR
  *TCN 2* rs1801198                 Total       CC                 CG                    GG                      AF          Total               CC                  CG    GG    AF                                  
  Martinelli et al.          2006   Caucasian   218                85                    110                     23          0.358               289                 89    150   50    0.433   0.330     5   PB      PCR
  Mills et al.               2008   Caucasian   316                99                    153                     64          0.445               1097                347   532   218   0.441   0.243     7   HB      Taqman
  Mostowska et al.           2010   Caucasian   163                46                    88                      29          0.448               181                 48    103   30    0.450   0.044     6   HB      Sequenom
  Jin et al.                 2015   Asian       429                76                    215                     138         0.572               461                 75    231   155   0.587   0.475     5   PB      Sequenom
  Waltrick-Zambuzzi et al.   2015   Caucasian   359                139                   160                     60          0.390               440                 179   199   62    0.367   0.576     7   Mixed   Sequenom
  Marini et al.              2016   Caucasian   330                135                   140                     55          0.379               366                 160   155   51    0.351   0.177     7   PB      PCR
  *BHMT* rs3733890                  Total       GG                 GA                    AA                      AF          Total               GG                  GA    AA    AF                                  
  Mostowska et al.           2010   Caucasian   174                95                    76                      3           0.236               176                 82    75    19    0.321   0.766     6   HB      PCR
  Hu et al.                  2011   Asian       166                90                    56                      20          0.289               268                 130   118   20    0.295   0.334     5   HB      PCR
  Jin et al.                 2015   Asian       481                219                   202                     60          0.335               554                 265   245   44    0.301   0.222     5   PB      PCR
  Marini et al.              2016   Caucasian   330                140                   150                     40          0.348               366                 156   163   47    0.351   0.665     7   PB      Sequenom
  Karas Kuzelicki et al.     2018   Caucasian   102                42                    51                      9           0.338               198                 98    84    16    0.293   0.734     7   HB      Q-PCR

Note: AF, allele frequency of minor allele; HB, hospital based; HWE, Hardy--Weinberg equilibrium; PB, population based.

Associations between the four SNPs of folate pathway gene and NSCL/P in the overall population {#sec3-2}
----------------------------------------------------------------------------------------------

The meta-analysis results showed that there was a significant association between rs1801133 and NSCL/P risk in two genetic models: TT genotype vs CC genotype (OR 1.333 95% CI=1.062--1.674, *P*= 0.013) and recessive model (OR=1.325 95%CI= 1.075--1.634, *P*= 0.008) ([Table 3](#T3){ref-type="table"}, [Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). There was no statistically significant association between rs1801394 of the *MTRR*, rs1801198 of the *TCN2*, rs3733890 of the *BHMT* and NSCL/P risk in the overall population ([Tables 4](#T4){ref-type="table"}--[6](#T6){ref-type="table"}).
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![Forest plot for pooled ORs for the associations between recessive model of rs1801133 and NSCL/P risk](bsr-40-bsr20194261-g4){#F4}

###### Association between the rs1801133 (CC/CT/TT\*) and NSCL/P

  Genetic model          *I^2^* (%)   *P* for heterogeneity   OR (95% CI)            *P* value     *P* for publication bias   Effects model
  ---------------------- ------------ ----------------------- ---------------------- ------------- -------------------------- ---------------
  T allele vs C allele                                                                                                        
    Overall              73.1         0                       1.111 (0.992--1.244)   0.069         0.820                      random
    Caucasian            58.5         0.001                   1.085 (0.976--1.206)   0.131         0.361                      random
    Asian                79.1         0                       1.244 (0.961--1.611)   0.098         0.438                      random
  TT vs CC                                                                                                                    
    Overall              62.6         0                       1.333 (1.062--1.674)   *0.013*^\#^   0.102                      random
    Caucasian            56.2         0.001                   1.230 (0.976--1.551)   0.080         0.239                      random
    Asian                70.5         0.001                   1.701 (0.949--3.049)   0.075         0.365                      random
  CT vs CC                                                                                                                    
    Overall              57.6         0                       1.026 (0.901--1.169)   0.696         0.587                      random
    Caucasian            40.3         0.033                   1.027 (0.904--1.166)   0.686         0.287                      random
    Asian                62.4         0.006                   1.081 (0.821--1.422)   0.580         0.041                      random
  Dominant model                                                                                                              
    Overall              66.2         0                       1.075 (0.936--1.234)   0.305         0.804                      random
    Caucasian            52.8         0.003                   1.067 (0.932--1.223)   0.347         0.208                      random
    Asian                67.9         0.002                   1.172 (0.883--1.557)   0.272         0.089                      random
  Recessive model                                                                                                             
    Overall              62.5         0                       1.325 (1.075--1.634)   *0.008*^\#^   0.220                      random
    Caucasian            40.9         0.030                   1.190 (0.989--1.433)   0.066         0.434                      random
    Asian                79.1         0                       1.737 (0.940--3.210)   0.078         0.404                      random

Note: \*wild homozygote (CC), heterozygote (CT), mutation (TT); ^\#^ indicates statistically significance.

###### Association between rs1801394 (AA/AG/GG\*) and NSCL/P

  Genetic model          *I^2^* (%)   *P* for heterogeneity   OR (95% CI)            *P* value     *P* for publication bias   Effects model
  ---------------------- ------------ ----------------------- ---------------------- ------------- -------------------------- ---------------
  G allele vs A allele                                                                                                        
    Overall              36.0         0.120                   0.986 (0.895--1.085)   0.766         0.713                      fixed
    Caucasian            0            0.938                   1.037 (0.928--1.158)   0.520         0.401                      fixed
    Asian                77.7         0.011                   0.863 (0.569--1.309)   0.488         0.480                      random
  GG vs AA                                                                                                                    
    Overall              30.7         0.172                   0.977 (0.781--1.223)   0.841         0.405                      fixed
    Caucasian            0            0.816                   1.176 (0.909--1.520)   0.217         0.218                      fixed
    Asian                0            0.820                   0.520 (0.321--0.841)   *0.008*^\#^   ---                        fixed
  AG vs AA                                                                                                                    
    Overall              78.3         0                       0.879 (0.630--1.227)   0.449         0.374                      random
    Caucasian            31.9         0.184                   1.037 (0.872--1.234)   0.679         0.443                      fixed
    Asian                93.2         0                       0.644 (0.211--1.968)   0.441         0.599                      random
  Dominant model                                                                                                              
    Overall              69.4         0.001                   0.921 (0.704--1.205)   0.550         0.586                      random
    Caucasian            0            0.514                   1.047 (0.886--1.236)   0.591         0.353                      fixed
    Asian                90.3         0                       0.746 (0.351--1.768)   0.506         0.908                      random
  Recessive model                                                                                                             
    Overall              37.8         0.117                   1.032 (0.853--1.248)   0.748         0.164                      fixed
    Caucasian            45.1         0.090                   1.062 (0.858--1.315)   0.581         0.073                      fixed
    Asian                39.6         0.198                   0.922 (0.605--1.406)   0.707         ---                        fixed

Note: \*wild homozygote (AA), heterozygote (AG), mutation (GG); ^\#^indicates statistically significance.

###### Association between rs1801198 (CC/CG/GG\*) and NSCL/P

  Genetic model          *I^2^* (%)   *P* for heterogeneity   OR (95% CI)            *P* value   *P* for publication bias   Effects model
  ---------------------- ------------ ----------------------- ---------------------- ----------- -------------------------- ---------------
  G allele vs C allele   38.8         0.147                   0.990 (0.907--1.080)   0.821       0.541                      fixed
  GG vs CC               43.4         0.116                   0.987 (0.824--1.181)   0.883       0.438                      fixed
  CG vs CC               0            0.820                   0.966 (0.840--1.112)   0.631       0.196                      fixed
  Dominant model         0            0.428                   0.976 (0.855--1.114)   0.717       0.248                      fixed
  Recessive model        27.4         0.229                   1.002 (0.860--1.167)   0.982       0.747                      fixed

Note: \*wild homozygote (CC), heterozygote (CG), mutation (GG).

###### Association between rs3733890 (GG/GA/AA\*) and NSCL/P

  Genetic model          *I^2^* (%)   *P* for heterogeneity   OR (95% CI)            *P* value   *P* for publication bias   Effects model
  ---------------------- ------------ ----------------------- ---------------------- ----------- -------------------------- ---------------
  A allele vs G allele   61.0         0.036                   0.994 (0.820--1.204)   0.948       0.409                      random
  AA vs GG               73.6         0.004                   0.993 (0.558--1.764)   0.980       0.182                      random
  GA vs GG               23.7         0.264                   0.968 (0.826--1.133)   0.685       0.961                      fixed
  Dominant model         33.2         0.200                   0.994 (0.856--1.155)   0.940       0.709                      fixed
  Recessive model        75.1         0.003                   1.002 (0.569--1.767)   0.994       0.192                      random

Note: \*wild homozygote (GG), heterozygote (GA), mutation (AA).

Subgroup analysis {#sec3-3}
-----------------

To decrease the heterogeneity, and a subgroup analysis was conducted according to genetic backgroud (i) Asian and (ii) Caucasian. The results showed that there was a significant association between rs1801394 and NSCL/P risk in Asian (GG genotype vs AA genotype, OR=0.520 95% CI=0.321--0.841, *P*= 0.008), but no associations in Caucasian ([Table 4](#T4){ref-type="table"}), which confers a protective role of GG genotype in Asian.

Meta-regression and influence analysis {#sec3-4}
--------------------------------------

Publication year, sample size and HWE were considered as covariates for meta-regression. The results showed that the above factors have no influence on the results (*P* \>0.05). To avoid one single study affected the overall OR estimates, one-way sensitivity analysis was performed. The results showed that no study was found to exert an excessive influence on the pooled effect.

Publication bias {#sec3-5}
----------------

There was publication bias for rs1801133 in the Asian population in genotype model CT vs CC ([Table 3](#T3){ref-type="table"}). Trim and fill results showed that the adjusted risk estimate unchanged, which confirmed that the results of present study are statistically reliable.

Discussion {#sec4}
==========

NSCL/P is a multifactorial disease caused by genetic and environmental factors. In previous years, various genomic susceptibility regions have been identified in association studies, linkage studies, family sequencing studies, and animal experiments suggesting that gene mutations influence the development of maxillofacial area. However, the underlying biological mechanisms remain unclear.

Folic acid is an important factor that influences the metabolism and the synthesis of nucleotides and amino acids. Previous studies have suggested that folic acid plays an important role in decreasing the risk of NSCL/P \[[@B2],[@B3]\]. Folic acid metabolism is a complex process and many genes are involved in the pathway, such as *MTHFR, MTRR, TCN2*, and *BHMT*. However, there are no consistent results regarding the association between the genetic variations of these genes and NSCL/P in different populations. To clarify these inconsistent results, we carried out the meta-analysis in this study.

The present meta-analysis results demonstrated a significant association between rs1801133 and NSCL/P risk in two genetic models: TT genotype vs CC genotype (OR=1.333 95% CI=1.062--1.674, *P*= 0.013) and recessive model (OR=1.325 95%CI = 1.075--1.634, *P* = 0.008). There were a significant protective association between rs1801394 GG genotype and NSCL/P in Asian (GG genotype vs AA genotype, OR=0.520 95% CI=0.321--0.841, *P*= 0.008).

*TCN2*, encode transcobalamin2, transports vitamin B12 to cells, have been reported to be associated with multiple diseases, such as cancer, Alzheimer and other congenital abnormalities \[[@B44]\]. In 2006, Martinelli et al*.* found that the C776G in *TCN2* was associated with risk of cleft lip, but subsequent studies didn\'t get the significant results \[[@B10]\]. Similarly, the present study didn\'t find the significant association between the C776G and NSCL/P.

BHMT, a zinc dependent cytosolic enzyme, is important for homocysteine metabolism and methionine synthesis. In 2010, Mostowska et al*.* first found that rs3733890 of the *BHMT* was associated with NSCL/P, and other studies also indicated its association with coronary artery disease and neural tube defects \[[@B23]\]. In the present study, we found no evidence showing rs3733890 playing any significant role \[[@B23]\]. We inferred several factors may contribute to the result. First, we found a relative high value of heterogeneity among studies, which cause a different distribution of genotype. Second, the number of included studies and sample size are relatively small. So, the subgroup analysis was not conducted based on ethnicity.

MTRR plays a vital role in functional regeneration of methionine synthase, and it may be associated with increasing the congenital heart disease risk \[[@B18]\]. But the meta-analysis conducted by Zhang et al*.* in 2013 and Lei et al*.* in 2018 showed no association between rs1801394 and the risk of NSCL/P \[[@B47],[@B48]\]. In the present study, we found a significant protective association between rs1801394 GG genotype and the NSCL/P risk in Asian, but no association in Caucasian. Considering the different background, we also summarized the data from 1000 genomes and ExAC database (S-[Table 1](#T1){ref-type="table"}), and we found the allelic frequencies vary in different background groups, and no significant association study between rs1801394 and the NSCL/P was found in Caucasian \[[@B6],[@B14],[@B25]\]. However, the sample size of the MTRR analysis is a limitation, and the present study did not consider the possibility of linkage disequilibrium, so further well-designed studies are required to establish these findings.

MTHFR is an important enzyme in homocysteine metabolism and C677T rs1801133 is one of the most important functional polymorphisms. Prediction by bioinformatics tools showed that the change of genetic variant will influence the protein function and predispose to cause the disease ([Table 1](#T1){ref-type="table"}). The allelic frequencies vary in different ethnic groups and the minor allele frequency (MAF) of *MTHFR* rs1801133 in Asian are lower than that in European and American, so it is very valuable to summarize and analyze by systematic statistical methods. In 1998, Tolarava found TT genotype of rs1801133 increase the risk of CL/P, later on, several studies also found the associations between rs1801133 and NSCL/P in different population \[[@B19],[@B29],[@B34]\]. However, there were several studies failed to find association between rs1801133 and the risk of NSCL/P \[[@B38],[@B41]\]. In the present study, we included 30 studies including 5517 cases and 7770 controls and found TT genotype can increase the risk of NSCL/P.

The strength of this meta-analysis is that it expands to a large number of related studies, and the most updated publications were included. A strict procedure for search strategy, literature inclusion, data extraction, and quality assessment by two researchers was performed to guarantee the quality. Meta-regression and sensitivity analysis were also performed to strengthen the conclusions. We confirmed the previous investigation by summarizing a larger number of closely related studies.

There are some limitations in the present meta-analysis. First, studies published only in English were included in the meta-analysis, and studies published in other languages were excluded. Second, environmental factors also contribute to NSCL/P, and in the present study, non-genetic factors and other potential interactions such as age, sex, folate level were not included in the analysis due to insufficient information.

Conclusion {#sec5}
==========

In the present study, we successfully identified rs1801133 in *MTHFR* is associated with the increasing risk of NSCL/P, and GG of rs1801394 in *MTRR* confers a protective role in Asian*.* Further well-designed studies are required to establish these findings.
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*BHMT*

:   betaine-homocysteine methyltransferase

HWE

:   Hardy--Weinberg equilibrium

MAF

:   minor allele frequency

*MTHFR*

:   methylenetetrahydrofolate reductase

*MTRR*

:   methionine synthase reductase

NSCL/P

:   nonsyndromic cleft lip with or without cleft palate

*TCN2*

:   transcobalamin

[^1]: These authors contributed equally to this work.
